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MONITORING PHYSIOLOGICAL VARIABLES WITH MEMBRANE PROBES
E. M. Janle, L. Yang and P. T. Kissinger
Bioanalytical Systems, Inc., West Lafayette, Indiana 47906
INTRODUCTION
Successful long-term ventures of humans into space will require a complete understanding of the effects of
microgravity on physiological systems and development of effective countermeasures to the deleterious effects of
long-term residence under these conditions. Accomplishing this task will require a significant amount of in vivo
research. Some of this can be ground-based simulations but much will have to be done in space. We have
developed membrane probes and technologies which will facilitate obtaining and processing samples both in
ground-based simulations and in on-board studies. Membrane probes also provide a method of studying
physiological changes in different tissues simultaneously and therefore provide more complete physiological
information than blood sampling alone.
Microdialysis and ultrafiltration probes employ hollow fibers, which can be implanted in living tissue for sample
collection. In microdialysis, an isosmotic perfusion fluid is passed through the fiber. Substances in the tissue, with
a smaller size than the molecular weight cut off of the membrane, diffuse across the membrane into the perfusion
fluid and are collected. In ultrafiltration, a negative pressure is applied to the fiber and interstitial fluid is passed
through the membrane, into the lumen and out of the animal.
In this project, we have validated microdialysis and ultrafiltration probes by in vitro recovery tests for
electrolytes sodium, potassium, and chloride and for the metabolites glucose and lactate. The use of these probes
in simulated microgravity research was demonstrated in the rodent mode.
METHODS
The ultrafiltration probe consisted of three 12-cm hollow fibers in a loop configuration bonded to a fluid
conduction tube. The microdialysis probe consisted of a 5-cm membrane in loop configuration, bonded at each end
to a fluid conduction tube. In vitro recovery tests were done by placing probes in a stirred solution of the analyte,
which was maintained at 37° C. Samples obtained from the probes were compared with samples of the original
solution. The range of concentrations investigated included the physiologically normal as well as pathologically
high and low concentrations.
Rats were implanted with subcutaneous microdialysis and ultrafiltration probes and jugular catheters. After
collecting baseline samples, the rats were placed in a suspension system with heads down and hind legs elevated
to simulate the fluid shifts of microgravity. After one to two weeks in the suspension system, the rats were
returned to the normal position for one week. Microdialysis samples were collectedevery two hours;
uitrafiltration samples were collected twice a day. Blood samples were collected daily until catheters failed.
Samples were analyzed for sodium, potassium, chloride, glucose, and lactate.
RESULTS
In vitro recoveries for each analyte are listed in table I.
Table I. In Vitro Recoveries
Analyte Ultrafiltration Microdialysis
Sodium 101%+ 2% 101%+2%
Potassium 94% + 13%
Chloride 96% + 4%
Glucose 99% + 3%
Lactate 94% + 5%
IO6%+ 4%
95% + 7%
90% + 10%
95% + 7%
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The implanted membrane probes provide a method for continuously monitoring changes in body chemistry.
Since no cells are removed there is no limit to the number of samples which can be obtained as there is with blood
sampling. Figure 1 illustrates the changes in subcutaneous and plasma sodium concentration during a baseline
control period, after suspension and during recovery. Sodium levels are stable during the baseline period. After
suspension there is an immediate decline in sodium below baseline followed by an elevation above baseline.
When suspension is ended, the concentrations return to baseline values during the recovery period.
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Figure 1. Subcutaneous ultrafiltrate and sodium concentrations in the rat during baseline control, head-down
suspension, and recovery.
CONCLUSIONS
The in vitro recoveries indicate that the microdialysis and ultrafiltration probes are suitable for use in sampling
these analytes.
The in vivo studies have demonstrated the potential of these techniques to obtain physiological data from animal
models. These probes have the potential to be coupled with on-line sensors which would make it possible to
acquire physiological data from animals in space without astronauts having to collect and store or process
samples. This will facilitate the study of the physiological effects of weightlessness and the development of
countermeasures.
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REAL TIME CONFOCAL LASER SCANNING MICROSCOPY: POTENTIAL
APPLICATIONS IN SPACE MEDICINE AND CELL BIOLOGY
Ana Rollan & Anthony P. McHale
Biotechnology Research Group, School of Applied Biological and Chemical Sciences,
University of Ulster, Coleraine, Co. Londonderry BT52 1SA, Northern Ireland.
INTRODUCTION
In more recent times technological advances in medicine have tended towards developing
non-invasive treatment modalities to replace more conventional invasive surgical procedures.
One example of this has been the development of photodynamic therapy for the relatively non-
invasive removal of abnormal tissues. This treatment morality involves the systemic
administration of a preparation known as a photosensitizer. This material is taken up by
abnormal tissues and subsequent irradiation of those tissues using low energy laser radiation
results in non-thermal activation of the photosensitizer and resultant cell death at the treated
site. In laboratory-based studies on photodynamic therapy (PDT) lasers such as low energy
HeNe lasers are used in conjunction with tissue culture systems. One problem associated
with this approach is that events occurring in real time at a microscopic level may not be
visualized. Here we report on the use of a real-time confocal laser scanning microscope
system (CLSM) in conjunction with photosensitized erythrocytes and we discuss its possible
applications in space medicine and cell biology.
METHODS
In these studies human erythrocytes were harvested from fresh blood, washed twice in
phosphate buffered saline and subsequently exposed to the photosensitizer (HPD) for 2 hours.
The cells were then washed and placed on microscope slides together with coverslips. These
were placed on the stage ofa Nikon Optiphot microscope equipped with a x60 objective lens.
This was coupled to an Odyssey confocal laser scanning system (ODYSSEY, Noran
Instruments Ltd., UK) with real time imaging facilities in order to facilitate direct examination
of the specimen during photodynamic activation. Activation was accomplished during
exposure to the visualizing scanning beam emitted by an Argon laser with multi-line emission
at 458nm/488nm/514nm/529nm. The microscope and scanning system were controlled by
the Odyssey software package loaded into a 486 IBM compatible PC, driven by Microsoft
Windows MS-DOS system. Images of events occurring during photoactivation couldbe
captttred using a conventional VCR system.
RESULTS
When non-photosensitized samples of erythrocytes were examined using the confocal system
it was found that the cells remained unchanged over a period of 1 hour, after which drying of
the samples contributed to distortions. However when samples were applied to the system
and the emission wavelength of that beam was set at 529nm a very dramatic disruptive event
was found to occur within 5 seconds exposure and all cells within the field had disappeared
within a 10-second period from the onset of exposure to the scanning beam. This suggested
that the system was capable of observing events at a microscopic level during photodynamic
activation. These results did not however give any indication at to whether or not the
observed events, recorded at a microscopic level, could be quantified. We therefore decided
to determine whether the disruptive event could be quantified with respect to photosensitizer
concentration and the intensity of the laser scanning beam. It was therefore decided to
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expose cells to three different photosensitizer concentrations and to subsequently visualize the
samples on the CLSM at various scanning beam intensities. The end point for this study was
chosen as the time taken for the onset of the disruptive event to occur once the samples were
exposed to the scanning beam. The results demonstrated that increasing the scanning beam
intensity decreased the time taken for photoactivation to occur. In addition, when the
photosensitizer concentration increased, the time taken for photoactivation to occur also
decreased. These results indicated a clear relationship between the events observed in real
time using the CLSM and both laser beam intensity and photosensitizer concentration.
In addition to carrying out these studies with erythrocytes, v,e have also used the CLSM
to examine living human HeLa cells which have been exposed to photosensitizers. In these
studies cells were also exposed to fluorescent probes which are only taken up by cells with
damaged membranes. The results from these studies will also be presented at the Symposium
as will potential applications of the system in space medicine and cell biology.
CONCLUSIONS
In ground-based studies, the CLSM system is capable of observing events which occur during
photodynamic activation in real time at a cellular level. Those events, in relations to our
studies with human erythrocytes may be quantified with respect to scanning beam dose and
photosensitizer dose. In the context of long and intermediate duration space flight we
envisage that modifications of the existing system offer significant potential both in studying
basic cellular function in a microgravity environment and capturing those events in real time
for subsequent transmission to ground-based laboratories. Because control of the basic
system is computer-based, the degree of expertise required by on-board personnel would be
minimal and extensive manipulation of the system could be ground-based. We believe that
such a system would have certain attractions for inclusion on-board the International Space
Station. In the context of space medicine we believe that the CLSM offers the potential for
developing non-invasive, remote medical procedures which would not necessitate return of
on-board personnel to Earth. It is also worth noting that the system offers the possibility of
carrying our tissue removal at a microscopic level and that removal may be monitored in real
time at a microscopic level. The system as outlined above with human erythrocytes has
already been suggested to offer potential as a drug delivery system in ground-based medical
procedures [Refs. 1 & 2]. We would intend to discuss the above possibilities in more detail at
the S3,rnposium.
REFERENCES
1. Flynn, G., McHale, L. & McHale, A.P. 1994, Methotrexate-loaded, photosensitized
erythrocytes: a photoactivatable carrier/delivery system for use in cancer therapy. Cancer
Letts. 82, 225-229.
2. Flynn, G., Hackett, T.J., McHale, L. & McHale, A.P. 1994, Encapsulation of the
thrombolytic enzyme brinase, in photosensitized erythrocytes: a novel thrombolytic system
based on photodynamic activation. J. Photochem. Photobiol. B - Biol. 26, 193 - 196.
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OPTIMUM VERSUS UNIVERSAL PLANETARY AND INTERPLANETARY HABITATS
Marc M. Cohen, Arch.D., Advanced Projects Branch, Space Projects Division, Mail Stop 244-14, NASA-Ames
Research Center, Moffett Field, CA 94035-1000
(415) 604-0068, FAX (415) 604-0763, mcohen @mall.arc, nasa. gov
INTRODUCTION
Habitats designed for interplanetary vehicles and planetary bases pose the challenge of substantial and significant
differences in each application. These differences encompass a wide range of functions and accommodations,
including radiation shielding, reliability strategy, gravity orientation, EVA alrlock, life support system closure,
laboratory facilities, countermeasures against weightlessness, pressure ports, and inflatable structures. This
comparison, detailed in Table 1, shows that these differences are very substantial and raise the question whether a
single habitat design can adaquetely perform the functions of supporting a human crew both in transit to Mars and on
the Mars surface.
UNIVERSAL HABITAT PRESSURE VESSEL
Despite these differences in functions and accommodations, it is unlikely that NASA could justify designing and
building two separate designs for large, human-rated pressure vessels. Estimates for planetary habitat pressure
vessels --conceived as a squat sylinder range from six to ten meters in diameter and from five to twelve meters in
height. Estimates for optimized interplanetary habitats -- conceived as a sphere or a nearly spherical ellipsoid --
range from seven to ten meters in diameter and from five to ten meters high. This paper will examine ways in
which it may be possible to design a single "universal habitat" pressure vessel module, that is easy to adapt to either
interplanetary or planetary use. This study will show the optimized, separate designs for planetary and interplanetary
habitat applications. It will propose and examine options for creating a "universal" habitat module that meets the
demands of both applications, without forcing unacceptable compromises upon either one.
PRESSURE VESSEL GEOMETRY
One key to successful pressure vessel design for these habitats is careful attention to the ellipsoidal geometry of
the end domes. By designing a dome of the most useful and appropriate depth and curvature, it is possible to meet
many of the mission demands without compromising essential capabilities. The primary cost comes in sacrificing
some modularity and standardization in interior secondary structures, stowage volumes and tankage.
CONCLUSION
This design research suggests that it is possible to create a near-optimized pressure vessel geometry that can
support both planetary and interplanetary crewed missions to Mars with minimum compromise to the capabilities of
either. The key to implementing this approach will be to treat planned customization as normal use, rather than as
an anamoly that requires waivers and special review.
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OPTIMUM VERSUS UNIVERSAL PLANETARY AND INTERPLANETARY HABITATS
TABLE 1. INTERPLANETARY VEHICLE AND PLANETARY HABITAT PARAMETERS
Design Parameter
1. Radiation Shielding
2. Reliability Strategy
3. Gravity Orientation
4. EVA Airlock
5. Life Support System Closure
6. Laboratory Facilities
7. Countermeasures Against
Weightlessness
8. Pressure Ports
9. Inflatable Structures
MISSION DESIGN IMPLICATIONS
Interplanetary Vehicle
Must launch to LEO, don't want to
drag it down to planet surface.
Propulsive character demands .99999
reliability.
Optimize for zero-gravity IVA
operations,
Landing in interplanetary vehicle
requires integration of heavy airlock
into Habitat.
Plan for physical / chemical closed-
loop regenerative system, with
possible plant-growth unit.
No use for the Lab Facilities
going to Mars, minimal use on return
vo),age.
Countermeasures such as a small
diameter, human-powered centrifuge
are essential to maintain crew health.
2 Ports at distal axial ends
No likely application
Planetar_ Surface Habitat
Can extract water from Mars
atmosphere or excavate regolith.
Availablity, resupply & repair
complement standard reliability
approaches.
Optimize for partial-g operations.
Separately landed habitat & airlock
allows on-surface assembly.
Plan for physical/chemical system
that includes local resources
(atmosphere) with CELSS component.
Laboratory will provide the center of
the Working Environment.
Zero-gravity countermeasures will be
less important in the .38 G gravity
field on Mars.
4 or more peripheral ports w/dust
control
Greenhouses, auxiliary and
supplementary facilities.
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Application of Remote Sensing and Geographic Information System
Technologies to the Prevention of Diarrheal Diseases in Nigeria
Philip C. Njemanze 1, Sheri W. Dieter 2, Brad M. Lobitz 2, Louisa R. Beck 2, Byron L.
Wood 2
I Institute of Space Medicine and Terrestrial Science, Chidicon Medical Center
Owerri, Imo State, Nigeria
2Center for Health Applications of Aerospace Related Technologies, JCI, NASA
Ames Research Center, Moffett Field CA
Abstract
Among the poor in developing countries up to 20% of an infant life experience
may be spent suffering from diarrheal illness, and up to one-third of deaths
among children less than 2years of age are due to complications of diarrheal
illness. This problem is spatially related to the lack of pure water at different sites.
Identification of the areas with poor water facilities and high incidence of diarrhea
is crucial to solving this problem. Conventional approaches used in Nigeria do not
take into account the spatial relationship between water availability and disease
patterns. This project will use remote sensing and geographic information system
(GIS) technologies to determine the optimal location for boreholes and other
clean water resources to prevent diseases. The initial study will focus on Imo and
Anambara States, Nigeria. The RS images of this area will be used to map
landcover, Isnduse, hydrology, towns, villages, and the major transportation
networks. The GIS database will also include spatial and quantitative
information on diarrheal disease patterns, population data, transportation
infrastructure, existing clean water facilities, human waste dumps, industrial
pollution sites, and other sources of contamination of water supply locations. The
location of potential clean water resources will be determined based on the
analysis of the database. Computer modeling will enable determination of the
impact of contamination, infrastructure malfunction, population changes, and
seasonal fluctuations. The experience gained in this study could be used on a
regional scale to guide funding agencies to implement water development
schemes. Such an approach could significantly reduce infant mortality due to
diarrheal diseases.
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A SMALL G LOADING HUMAN CENTRIFUGE FOR SPACE STATION ERA
K. Yajima, K. Iwasaki, R. Murai, T. Nakazato, M. Itoh, K. Hirayanagi, A. Miyamoto and M.
Igarashi
Department of Hygiene/Space Medicine, School of Medicine, Nihon University
INTRODUCTION
Human centrifugations were conducted using a short arm (1.8 m radius) centrifuge ( First Medical Co. Japan).
Long-duration exposure to the microgravity environment in space would pcoduce various biomedical problems
including cardiovascular deconditioning, bone-demineralization, muscle atrophy, etc. Usefulness of a short-radius
human centrifuge is expected when it is used in space as a countermeasure against these problems. Especially,
centrifugation has been considered as an only solution in a long term micro gravity exposure to prevent a calcium
loss from the bone. However almost nothing is well established regarding the most desirable program for
artificial G application. Moreover, we definitely need to understand more details about the effects of long
duration small +Gz(1-3G) on human. We have studied for many years to solve these points using a short ann
centrifuge on the ground. This is an overview of our experiments from the early stage up to the present.
METHODS
Nihon university's short-radius human centrifuge was used for 6 study series. 151 healthy male subjects
aged 21 - 39 were informed and chosen for this series of experiments. They received G load along the body's +z
axis. The data were collected on sitting position during the load. Electrocardiogram (ECG) was obtained from the
third lead and systolic blood pressure (SBP) and diastolic blood pressure (DBP) were obtained with Life Scope 8
(Nihon-Koden). We also observe Arterial Oxygen Saturation by a pulse oximeter since Series B. Sympathetic and
parasympathetic activities were evaluated with R-R interval spectral analysis.
In these studies the G load was discontinued when the subject complained of the symptoms by the G load or
when the experimenter judged to discontinue based on his evaluation of the subject's physical condition.
RESULTS
The acceleration protocol, G level, and exposure time, the total number of subjects and the number of subjects
who completed the exposure time are shown in table I.
The number of subjects who could not tolerate the load, and the causes of discontinue are shown in table II.
A, B, C, D, E and F are the series timely sequenced, and G parameters, such as acceleration protocol,
acceleration period, G level and exposure time, have been changed by the previous results, aiming to get the more
G and the longer exposure time. By the same reason, the centrifuge itself and its inner devices also have been
improved year by year accx_ding to the time pass. Then we could gradually neglect the side effects of our short-
radius human centrifuge, such as naus_ or vertigo.
CONCLUSION
We have studied for many years to understand more details about the effects of long duration small +Gz on
human, using short-radius centrifuge on the ground. We have improved our centrifuge and program of artificial G
application. Then we could gradually neglect the side effects. However, when we study the usefulness of a short-
radius centrifuge, the potential effects of various factors in space need to be considered as well.
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USE OF THE BICYCLE ERGOMETER ON THE INTERNATIONAL SPACE STATION
AND ITS INFLUENCE ON THE MICROGRAVITY ENVIRONMENT
N. Penley I and G. Banta 2
2
IMicrogravity Payloads Office (0Z4), Johnson Space Center, Houston, Texas 77058, Science Applications
International Corporation
INTRODUCTION
A number of exercise techniques have been employed routinely aboard Shuttle and MIR. These same techniques
and others are planned for use aboard the International Space Station (ISS) for extended space missions. Peddling
on a bicycle ergometer, an endurance exercise, is one exercise technique that will be used to maintain Astronaut
respiratory capacity, minimize loss in work capacity, and perhaps increase circulating blood volume.
Operation of the ergometer has however, stimulated some concern for the Space Station Payload Office. Those
concerns relate to whether ergometer operation and its location will have an influence on the microgravity payload
environment. The microgravity environment generally requires acquiescence. To properly address these concerns,
review of isolated and non-isolated ergometer operations are necessary.
METHODS
To assess potential loads (microgravity disturbance) that might be generated for the ergometer aboard the ISS,
data from both KC-135 parabolic flights (non-isolated) and two Orbitor flights (isolated) were reviewed. The
Orbitor flight tests used both a Passive Cycle Isolation System (PCIS) and an Inertial Vibration Isolation System
(IVIS). KC-135 flights to collect microgravity disturbance of an isolated ergometer are under consideration for early
spring. The test criteria and data will be compared to the KC-135 non-isolated tests.
RESULTS
KC- 135 test data (non-isolated) was assessed by frequency range and amplitude for the MIR ergometer, the
Orbitor ergometer, and a proposed ISS ergometer. Disturbances ranged from 0.05 to 5.5 Hz. A wide range of
microgravity environment disturbances can also be seen for the two Orbitor flights depending on location and
subject peddling technique. These data as well as results of KC-135 isolated ergometer tests, if flown, will be
reviewed and presented.
CONCLUSION
Preliminary data analysis from KC-135 non-isolated and Shuttle isolated bicycle ergometer testing suggests
potential for microgravity environment disturbance aboard the ISS. These disturbances may be accentuated by
location of the ergometer as well as the time period of its use. This type of information will aid ISS research
planners in determining the best location of the exercise equipment, methods of its use, and periods of its operation
as related to other essential microgravity payloads.
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MUNICH SPACE CHAIR (MSC) - A NEXT GENERATION BODY RESTRAINT SYSTEM
FOR ASTRONAUTS
E. lgenbergs _, W. Naumann 1,P. Eckart _,E. Pfeiffer a
qnstitute of Astronautics, Technical University of Munich, 85747 Garching; 2Kayser-Threde GmbH, Munich
email office@asterix.lrt.mw.tu-muenchen.de
INTRODUCTION
The microgravity environment onboard orbital facilities greatly influences working conditions. On the one hand,
the lack of gravitation facilitates the moving from one place to another; on the other hand it makes it more difficult
to rest in a stable position. As a prevention from floating away, astronauts have to hold with one hand a grip or
handrail, or clamp another part of their body between available facilities. To avoid this and to lower the restrictions
due to 0-g, many different body restraint systems have been developed and used onboard spacecrafts and space
stations. The most common ones are footloops and handrails. Unlike most of these different restraint systems, the
Munich Space Chair (MSC) gives astronauts the possibility to fix their bodies very rigidly while staying relaxed
even during work under high muscular strain and long working conditions.
FIXATION PRINCIPLE
The concept of the MSC is based on ergonomic aspects. It fixes a
human body in its neutral 0-g position without the need for additional
supports like belts, e.g. The sitting posture of the MSC is combined
with a simple fixation principle. As depicted in the figure, the human
body is fixed between foot bar, thigh plate and seat plate. The astro-
naut only has to press his thigh against the thigh plate by stretching
his foot and spanning his calf muscles, respectively. Due to the
leverage of the thigh plate, the back is pressed onto the seat plate. The
whole lower part is fixed while the upper part of the body with the
arms keeps its freedom. Depending only on the muscle employment
of the astronaut, it is possible to ,,sit" in the Chair being fixed very
tightly or rather loosely or ,,free floating" within the three fixing
points. So the fixation can be easily varied for different tasks.
Furthermore the MSC can be adapted to all body sizes.
DEVELOPMENT AND APPLICATION ON MIR
The MSC was tested in three parabolic flight campaigns and opti-
mised according to the results. A detailed load analysis was per-
formed to get the limit loads induced to the MSC by the astronaut. In
Munich Space Chair with adjust- 1995, more than 10 years after the invention of the space chair, the
able work table MSC was launched to Space Station MIR and installed inside the
SPEKTR module. In October 1995, an adjustable and foldable work
table for the MSC was also sent up to MIR in a PROGRESS cargo spacecraft. During the EUROMIR'95 mission,
the MSC was used for experimental activities, writing and typing. Moreover, it was tried to verify an improvement
of concentration abilities and precise movements using the MSC for the DLR experiment PSY-15 D, which requires
precise work with both hands under high concentration over a long period of time. German Astronaut Thomas
Reiter, who spent 6 months onboard MIR, confirmed the expected improvements compared to other restraints for
this kind of application. Another MSC main duty onboard MIR, the support of the mechanical PELIKAN manipu-
lator arm operation, has not yet begun.
OUTLOOK
Presently, several components of the MSC are adapted for future use onboard the International Space Station
(ISS). Especially, the floor connection unit is redesigned to enable a connection to the seat tracks inside the ISS. The
use of the MSC onboard the ISS will complete the required range of restraint systems.
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THERMOELECTRIC HUMAN-BODY COOLING UNITS USED BY NASA SPACE
SHUTTLE ASTRONAUTS
Pat Heenan s, Roy Theisen _,B. MathiPrakasam _, Stephanie Walker 2, and Bruce Sauser 2
IMidwest Research Institute, Kansas City, USA; 2NASA Johnson Space Center, Houston, USA
INTRODUCTION
The US National Aeronautics and Space Administration (NASA) realized a need for a cooling system that can provide
body cooling to the space shuttle astronauts and thus reduce heat stress while they wear the Launch Entry Suit during
shuttle launch and reentry. Midwest Research Institute (MRI) developed thermoelectric (TE) cooling units to meet this
need. First generation cooling units developed by MRI are being used by the astronauts during the last three years.
Second generation cooling units are currently under development and will become available for 1997 missions. The
cooling units are used in conjunction with NASA-furnished tube-type cooling garments. The paper will discuss the
technicaldetailsof body coolingneedsofastronauts,econdgenerationTE coolingunits,and theperformanceresults,
BODY COOLING NEEDS
The metabolic heat produced by an average astronaut's body is about 100 watts. Since the astronauts wear the Launch
Entry Suits for survival reasons during shuttle launch and reentry, the produced heat cannot be rejected to the cabin air.
Body cooling is done by wearing a special tubes-sown garment adjacent to the body skin and by circulating a chilled
fluid through the garment tubes. A cooling unit is required to rechill the warm liquid returning from the garment.
COOLING UNITS
The second generation TE cooling units are compact, lightweight, and efficient. Each unit weighs about 6.5 lb and has
a size of 4 X 5 X 8.5 in. The principal components of a unit are (1) a cooler core, (2) a fan, (3) a fluid pump, (4) an
electronic PC board, and (5) an enclosure. The core contains the TE modules, fluid cooling channels, and heat sinks. In
operation, power is applied to the TE modules, fan, and pump. The warm fluid returning from the garment is pumped
through the cooling channels of the core and thus cooled. The fan circulates cabin air through the heat sinks to remove
the heat rejected by the TE modules. A 10-position wired-remote switch is used by each astronaut to regulate the power
applied to the TE modules and thus vary the cooling delivered to the body.
PERFORMANCE RESULTS
The cooling unit is capable of delivering up to 150 watts of cooling in a 750 F cabin temperature. The maximum
delivered cooling reduces to about 105 watts (and is still sufficient to balance the metabolic heat produced by an average
astronaut) when the cabin temperature increases to 900 F. To deliver 1O0 cooling watts, the electrical power
requirements of the cooling unit at 28 VDC are 25 and 60 watts respectively at 750 F and 900 F cabin temperature.
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